Correction to: Cell Research https://doi.org/10.1038/s41422-021-00495-9; published online 19 March 2021
We apologize for an error in this paper online published on Mar 19, 2021. There is a mistake on the title where “TRL41” should be “TLR4”. This correction does not affect the description of the results or the conclusion of this work. We apologize for not detecting them before publication and any inconvenience caused. The correct title should be as follows:
SARS-CoV-2 spike protein interacts with and activates TLR4
Author information
Authors and Affiliations
Corresponding authors
Additional information
The original article can be found online at https://doi.org/10.1038/s41422-021-00495-9.
Rights and permissions
About this article
Cite this article
Zhao, Y., Kuang, M., Li, J. et al. Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4. Cell Res 31, 825 (2021). https://doi.org/10.1038/s41422-021-00501-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41422-021-00501-0
This article is cited by
-
Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsis
Signal Transduction and Targeted Therapy (2023)
-
Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes
Cell Discovery (2022)
-
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
Nature Immunology (2022)
